Multi-scale mechanism of antiviral drug-alike phytoligands from Ayurveda in managing COVID-19 and associated metabolic comorbidities: insights from network pharmacologyArticle Published on 2022-10-012022-11-15 Journal: Molecular diversity [Category] [DOI] 10.1007/s11030-021-10352-x PMC 바로가기
Therapeutic and palliative role of a Unani herbal decoction in COVID-19 and similar respiratory viral illnesses: Phytochemical & pharmacological perspectiveReview article Published on 2022-10-012022-10-05 Journal: Journal of ethnopharmacology [Category] [DOI] 10.1016/j.jep.2022.115526 [Article Type] Review article
Letter to Editor on “A randomized, controlled, blinded, parallel-group, clinical trial to study the role of Ayurcov (AyurCoro3), a one-day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India”Randomized Controlled Trial Published on 2022-09-012022-10-05 Journal: Complementary therapies in medicine [Category] [DOI] 10.1016/j.ctim.2022.102838 PMC 바로가기 [Article Type] Randomized Controlled Trial
AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized controlled intervention trialClinical Trial Published on 2022-08-162022-10-04 Journal: Frontiers in Public Health [Category] [DOI] 10.3389/fpubh.2022.920126 PMC 바로가기 [Article Type] Clinical Trial
Methodological analysis of CTRI registered clinical trials on Ayurveda interventions for COVID-19 managementReview article Published on 2022-08-012022-10-05 Journal: Journal of Ayurveda and Integrative Medicine [Category] [DOI] 10.1016/j.jaim.2022.100631 [Article Type] Review article
A randomized, controlled, blinded, parallel group, clinical trial to study the role of Ayurcov (AyurCoro3), one day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India인도의 코비드 전용 병원(DCH)에서 COVID-19 질병 관리를 위한 보조 요법으로서 Ayurcov(AyurCoro3)의 역할을 연구하기 위한 무작위, 통제, 맹검, 병렬 그룹 임상 시험Randomized Controlled Trial Published on 2022-08-012022-09-11 Journal: Complementary therapies in medicine [Category] [DOI] 10.1016/j.ctim.2022.102824 PMC 바로가기 [Article Type] Randomized Controlled Trial
Impact of AYUSH 64 as an adjunctive to standard of care in mild COVID 19 – An open-label randomized controlled pilot studyShort communication Published on 2022-07-012022-10-05 Journal: Journal of Ayurveda and Integrative Medicine [Category] [DOI] 10.1016/j.jaim.2022.100587 [Article Type] Short communication
COVID-19 patient with B Cell Lymphoma co-morbidity managed with co-administration of Ayurvedic formulationCase report Published on 2022-07-012022-10-05 Journal: Journal of Ayurveda and Integrative Medicine [Category] [DOI] 10.1016/j.jaim.2022.100632 [Article Type] Case report
AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, IndiaRandomized Controlled Trial Published on 2022-06-012022-10-04 Journal: Complementary therapies in medicine [Category] [DOI] 10.1016/j.ctim.2022.102814 PMC 바로가기 [Article Type] Randomized Controlled Trial
Efficacy and safety of AYUSH-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic reviewArticle Published on 2022-05-242023-07-09 Journal: Systematic Reviews [Category] [DOI] 10.1186/s13643-022-01983-8 PMC 바로가기